Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Noga Gershoni Emek"'
Autor:
Michal Geva, Noga Gershoni-Emek, Luana Naia, Philip Ly, Sandra Mota, Ana Cristina Rego, Michael R. Hayden, Leonard A. Levin
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-16 (2021)
Abstract Optic neuropathies such as glaucoma are characterized by retinal ganglion cell (RGC) degeneration and death. The sigma-1 receptor (S1R) is an attractive target for treating optic neuropathies as it is highly expressed in RGCs, and its absenc
Externí odkaz:
https://doaj.org/article/ca78b753223b4e7397379916ee16da40
Autor:
Sophie Lenoir, Romane A. Lahaye, Hélène Vitet, Chiara Scaramuzzino, Amandine Virlogeux, Laetitia Capellano, Aurélie Genoux, Noga Gershoni-Emek, Michal Geva, Michael R. Hayden, Frédéric Saudou
Publikováno v:
Neurobiology of Disease, Vol 173, Iss , Pp 105857- (2022)
Huntington disease (HD) is a neurodegenerative disorder caused by polyglutamine-encoding CAG repeat expansion in the huntingtin (HTT) gene. HTT is involved in the axonal transport of vesicles containing brain-derived neurotrophic factor (BDNF). In HD
Externí odkaz:
https://doaj.org/article/fd15b7293989424cb83b9058a66155a8
Autor:
Noga Gershoni-Emek, Topaz Altman, Ariel Ionescu, Christopher J. Costa, Tal Gradus-Pery, Dianna E. Willis, Eran Perlson
Publikováno v:
Frontiers in Molecular Neuroscience, Vol 11 (2018)
Local protein synthesis in neuronal axons plays an important role in essential spatiotemporal signaling processes; however, the molecular basis for the post-transcriptional regulation controlling this process in axons is still not fully understood. H
Externí odkaz:
https://doaj.org/article/2bb6ee217fce4e6d929ac1aeba9e33c6
Autor:
Michal Geva, Deniz Akinc Abdulhayoglu, Shao-Ming Wang, Noga Gershoni-Emek, Bruno Boulanger, Y Paul Goldberg, Tsung-Ping Su, Michael R Hayden
Publikováno v:
J: Clinical therapeutics.
Autor:
Michal Geva, Deniz Akinc Abdulhayoglu, Noga Gershoni-Emek, Y Paul Goldberg, Bruno Boulanger, Michael R Hayden
Publikováno v:
D: Wet biomarkers.
Autor:
Michal Geva, Chiara Scaramuzzino, Sophie Lenoir, Romane A Lahaye, Shao-Ming Wang, Hsiang-en Wu, Noga Gershoni-Emek, Frédéric Saudou, Tsung-Ping Su, Michael R Hayden
Publikováno v:
I: Experimental therapeutics – preclinical.
Autor:
Sophie Lenoir, Romane A. Lahaye, Hélène Vitet, Chiara Scaramuzzino, Amandine Virlogeux, Laetitia Capellano, Aurélie Genoux, Noga Gershoni-Emek, Michal Geva, Michael R. Hayden, Frédéric Saudou
Publikováno v:
Neurobiology of disease. 173
Huntington disease (HD) is a neurodegenerative disorder caused by polyglutamine-encoding CAG repeat expansion in the huntingtin (HTT) gene. HTT is involved in the axonal transport of vesicles containing brain-derived neurotrophic factor (BDNF). In HD
Autor:
Ana Cristina Rego, Philip T. T. Ly, Noga Gershoni-Emek, Leonard A. Levin, Luana Naia, Sandra I. Mota, Michael R. Hayden, Michal Geva
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-16 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-16 (2021)
Optic neuropathies such as glaucoma are characterized by retinal ganglion cell (RGC) degeneration and death. The sigma-1 receptor (S1R) is an attractive target for treating optic neuropathies as it is highly expressed in RGCs, and its absence causes
Autor:
C. Warren Olanow, Munish Mehra, Andrew McGarry, Noga Gershoni Emek, Michael R. Hayden, Karl Kieburtz, Michal Geva
Publikováno v:
F: Clinical studies: case reports, observational studies and trials.
Autor:
Jennifer Dreymann, Michael R. Hayden, Deniz Akinc Abdulhayoglu, Noga Gershoni Emek, Michal Geva, Y. Paul Goldberg, Bruno Boulanger, Charles Li
Publikováno v:
F: Clinical studies: case reports, observational studies and trials.